Request for Covid-19 Impact Assessment of this Report
The key regions considered for the global Veterinary Oncology Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the veterinary oncology market. Over the forecast period, the segment is expected to dominate the market. The growing focus on pet health, the presence of a large number of pet medicine manufacturing companies, and the rapid acceptance of novel pet care medications are all contributing to market growth. Furthermore, the government's increased support for pet oncology treatment in this region, as well as the existence of market behemoths in the oncology market, are boosting the market. The market in Asia Pacific is likely to develop over the forecast period as veterinarians become more aware of various treatment procedures for pets, veterinary healthcare infrastructure improves, and animal healthcare expenditure rises.
Major market player included in this report are:
PetCure Oncology
Zoetis
Karyopharm Therapeutics, Inc.
Varian Medical Systems
Accuray Incorporated
Boehringer Ingelheim GmbH
Elanco
One Health
Regeneus Ltd.
Morphogenesis, Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapy
Surgery
Radiotherapy
Chemotherapy
Immunotherapy
Others
By Animal type:
Canine
Feline
By Cancer Type:
Lymphoma
Mast Cell Cancer
Mammary and Squamous Cell Cancer
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Veterinary Oncology Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Veterinary Oncology Market, by Region, 2020-2028 (USD Million)
1.2.2. Veterinary Oncology Market, by Therapy, 2020-2028 (USD Million)
1.2.3. Veterinary Oncology Market, by Animal Type, 2020-2028 (USD Million)
1.2.4. Veterinary Oncology Market, by Cancer Type, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Veterinary Oncology Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Veterinary Oncology Market Dynamics
3.1. Veterinary Oncology Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increasing pervasiveness of cancer in the pet population
3.1.1.2. Growing expenditure on animal healthcare
3.1.2. Market Challenges
3.1.2.1. High cost of veterinary cancer therapy
3.1.2.2. Side effects of oncology medications including as hair loss, decreased appetite, and vomiting
3.1.3. Market Opportunities
3.1.3.1. Increasing number of veterinary clinical studies for evaluating safety and efficacy of different oncologic treatments in pets.
3.1.3.2. Supportive government initiatives pertinent to veterinary cancer treatment
Chapter 4. Global Veterinary Oncology Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Veterinary Oncology Market, by Therapy
6.1. Market Snapshot
6.2. Global Veterinary Oncology Market by Therapy, Performance - Potential Analysis
6.3. Global Veterinary Oncology Market Estimates & Forecasts by Therapy 2018-2028 (USD Million)
6.4. Veterinary Oncology Market, Sub Segment Analysis
6.4.1. Surgery
6.4.2. Radiotherapy
6.4.3. Chemotherapy
6.4.4. Immunotherapy
6.4.5. Others
Chapter 7. Global Veterinary Oncology Market, by Animal Type
7.1. Market Snapshot
7.2. Global Veterinary Oncology Market by Animal Type, Performance - Potential Analysis
7.3. Global Veterinary Oncology Market Estimates & Forecasts by Animal Type 2018-2028 (USD Million)
7.4. Veterinary Oncology Market, Sub Segment Analysis
7.4.1. Canine
7.4.2. Feline
Chapter 8. Global Veterinary Oncology Market, by Cancer Type
8.1. Market Snapshot
8.2. Global Veterinary Oncology Market by Cancer Type, Performance - Potential Analysis
8.3. Global Veterinary Oncology Market Estimates & Forecasts by Cancer Type 2018-2028 (USD Million)
8.4. Veterinary Oncology Market, Sub Segment Analysis
8.4.1. Lymphoma
8.4.2. Mast Cell Cancer
8.4.3. Mammary and Squamous Cell Cancer
8.4.4. Others
Chapter 9. Global Veterinary Oncology Market, Regional Analysis
9.1. Veterinary Oncology Market, Regional Market Snapshot
9.2. North America Veterinary Oncology Market
9.2.1. U.S. Veterinary Oncology Market
9.2.1.1. Therapy breakdown estimates & forecasts, 2018-2028
9.2.1.2. Animal Type breakdown estimates & forecasts, 2018-2028
9.2.1.3. Cancer Type breakdown estimates & forecasts, 2018-2028
9.2.2. Canada Veterinary Oncology Market
9.3. Europe Veterinary Oncology Market Snapshot
9.3.1. U.K. Veterinary Oncology Market
9.3.2. Germany Veterinary Oncology Market
9.3.3. France Veterinary Oncology Market
9.3.4. Spain Veterinary Oncology Market
9.3.5. Italy Veterinary Oncology Market
9.3.6. Rest of Europe Veterinary Oncology Market
9.4. Asia-Pacific Veterinary Oncology Market Snapshot
9.4.1. China Veterinary Oncology Market
9.4.2. India Veterinary Oncology Market
9.4.3. Japan Veterinary Oncology Market
9.4.4. Australia Veterinary Oncology Market
9.4.5. South Korea Veterinary Oncology Market
9.4.6. Rest of Asia Pacific Veterinary Oncology Market
9.5. Latin America Veterinary Oncology Market Snapshot
9.5.1. Brazil Veterinary Oncology Market
9.5.2. Mexico Veterinary Oncology Market
9.6. Rest of The World Veterinary Oncology Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. PetCure Oncology
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Therapy Summary
10.2.1.5. Recent Developments
10.2.2. Zoetis
10.2.3. Karyopharm Therapeutics, Inc.
10.2.4. Varian Medical Systems
10.2.5. Accuray Incorporated
10.2.6. Boehringer Ingelheim GmbH
10.2.7. Elanco
10.2.8. One Health
10.2.9. Regeneus Ltd.
10.2.10. Morphogenesis, Inc
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
TABLE 1. Global Veterinary Oncology Market, report scope
TABLE 2. Global Veterinary Oncology Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Veterinary Oncology Market estimates & forecasts by Therapy 2018-2028 (USD Million)
TABLE 4. Global Veterinary Oncology Market estimates & forecasts by Animal Type 2018-2028 (USD Million)
TABLE 5. Global Veterinary Oncology Market estimates & forecasts by Cancer Type 2018-2028 (USD Million)
TABLE 6. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. Global Veterinary Oncology Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. Global Veterinary Oncology Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 16. U.S. Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 17. U.S. Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 18. U.S. Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. Canada Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 20. Canada Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 21. Canada Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. UK Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 23. UK Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 24. UK Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. Germany Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 26. Germany Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 27. Germany Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. RoE Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 29. RoE Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 30. RoE Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. China Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 32. China Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 33. China Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. India Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 35. India Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 36. India Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. Japan Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 38. Japan Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 39. Japan Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. RoAPAC Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 41. RoAPAC Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 42. RoAPAC Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. Brazil Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 44. Brazil Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 45. Brazil Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Mexico Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 47. Mexico Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 48. Mexico Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. RoLA Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 50. RoLA Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 51. RoLA Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. Row Veterinary Oncology Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 53. Row Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 54. Row Veterinary Oncology Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 55. List of secondary sources, used in the study of global Veterinary Oncology Market
TABLE 56. List of primary sources, used in the study of global Veterinary Oncology Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...